Abstract Library

#2111 Biliary Neuroendocrine Tumors: A Retrospective Analysis of 28 Patients Since 1991

Introduction: Biliary neuroendocrine tumors represent less than 1% of all neuroendocrine tumors (NETs), and the related clinical study is limited.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Zheng Z

Authors: Zheng Z, Chen C, Xie Y, Zheng C, Li B,

Keywords: neuroendocrine tumor, neuroendocrine carcinoma, biliary tract,

#1773 Clinical Outcomes of Systemic Chemotherapy in Patients with High Grade Neuroendocrine Carcinoma of Biliary Tract

Introduction: : Neuroendocarine tumor of biliary tract is very rare and clinical outcomes of advanced neuroendocrine tumors of biliary tract has not been well demonstrated.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Yoo C, Lee K, Kim K, Chang H, Ryoo B,

Keywords: biliary tract, high grade, neuroendocrine carcinoma,

#1477 Neuroendocrine Tumors of the Biliary Tract: A Retrospective, Observational Multicenter Study

Introduction: Neuroendocrine tumors of the biliary tract (BTNETs) constitute a heterogeneous group of neoplasms. Because of their rarity, the clinical behavior is unclear.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Brizzi M, Massironi S, Pusceddu S, De Nigris B, Birocco N,

Keywords: Biliary tract NET,

#991 Primary Neuroendocrine Tumor of Extrahepatic Bile Duct

Introduction: Biliary tract primary malignant tumors are rare neoplasms. Eighty-five per cent are cholangiocarcinomas, being in exceptional cases a neuroendocrine tumor. The absence of clinical suspiction involves a difficult preoperative diagnosis.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Flores Garcia J

Authors: Flores Garcia J, Galeano Diaz F, Barzola Navarro E, Tejera Pérez C, Rubio Fernandez A,

Keywords: primary bile duct tumor, neuroendocrine tumor, nonfunctioning neuroendocrine tumor,

#90 The prognostic value of FDG-PET scan in neuroendocrine tumors: a retrospective analysis of 46 patients treated in one center

Introduction: Neuroendocrine tumors (NETs) are rare and generally indolent. For diagnostic purposes, the sensitivity of FDG-PET scan is known to be low in this setting, though when positive, its prognostic value is not well-defined in NET.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Borbath I

Authors: Sacré F, Lhommel R, Lonneux M, Gigot J, Sempoux C,

Keywords: neuroendocrine tumors, PET-FDG, prognosis,